MYC, Metabolism, and Cancer
Tóm tắt
The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its precise oncogenic role enigmatically elusive. The evidence to date suggests that MYC triggers selective gene expression amplification to promote cell growth and proliferation. Through its targets, MYC coordinates nutrient acquisition to produce ATP and key cellular building blocks that increase cell mass and trigger DNA replication and cell division. In cancer, genetic and epigenetic derangements silence checkpoints and unleash MYC's cell growth– and proliferation-promoting metabolic activities. Unbridled growth in response to deregulated MYC expression creates dependence on MYC-driven metabolic pathways, such that reliance on specific metabolic enzymes provides novel targets for cancer therapy.
Significance: MYC's expression and activity are tightly regulated in normal cells by multiple mechanisms, including a dependence upon growth factor stimulation and replete nutrient status. In cancer, genetic deregulation of MYC expression and loss of checkpoint components, such as TP53, permit MYC to drive malignant transformation. However, because of the reliance of MYC-driven cancers on specific metabolic pathways, synthetic lethal interactions between MYC overexpression and specific enzyme inhibitors provide novel cancer therapeutic opportunities. Cancer Discov; 5(10); 1024–39. ©2015 AACR.
Từ khóa
Tài liệu tham khảo
Conacci-Sorrell, 2014, An overview of MYC and its interactome, Cold Spring Harb Perspect Med, 4, a014357, 10.1101/cshperspect.a014357
Duesberg, 1977, The RNA of avian acute leukemia virus MC29, Proc Natl Acad Sci U S A, 74, 4320, 10.1073/pnas.74.10.4320
Sheiness, 1978, Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29, J Virol, 28, 600, 10.1128/jvi.28.2.600-610.1978
Bister, 1986, Oncogenes in retroviruses and cells: biochemistry and molecular genetics, Adv Cancer Res, 47, 99, 10.1016/S0065-230X(08)60199-2
Dalla-Favera, 1982, Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells, Proc Natl Acad Sci U S A, 79, 7824, 10.1073/pnas.79.24.7824
Land, 1983, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes, Nature, 304, 596, 10.1038/304596a0
Zack, 2013, Pan-cancer patterns of somatic copy number alteration, Nat Genet, 45, 1134, 10.1038/ng.2760
Morton, 2013, MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC, Mol Oncol, 7, 248, 10.1016/j.molonc.2013.02.015
Lal, 2009, miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements, Mol Cell, 35, 610, 10.1016/j.molcel.2009.08.020
Kim, 2009, HuR recruits let-7/RISC to repress c-Myc expression, Genes Dev, 23, 1743, 10.1101/gad.1812509
Sampson, 2007, MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells, Cancer Res, 67, 9762, 10.1158/0008-5472.CAN-07-2462
Wall, 2008, Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation, Blood, 112, 2305, 10.1182/blood-2007-09-111856
Tseng, 2014, PVT1 dependence in cancer with MYC copy-number increase, Nature, 512, 82, 10.1038/nature13311
Sears, 2000, Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability, Genes Dev, 14, 2501, 10.1101/gad.836800
Magudia, 2012, K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc, J Cell Biol, 198, 185, 10.1083/jcb.201202108
Lee, 2010, ERK activation drives intestinal tumorigenesis in Apc(min/+) mice, Nat Med, 16, 665, 10.1038/nm.2143
Hung, 2014, A long noncoding RNA connects c-Myc to tumor metabolism, Proc Natl Acad Sci U S A, 111, 18697, 10.1073/pnas.1415669112
Yashiro-Ohtani, 2014, Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia, Proc Natl Acad Sci U S A, 111, E4946, 10.1073/pnas.1407079111
Herranz, 2014, A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia, Nat Med, 20, 1130, 10.1038/nm.3665
Shi, 2013, Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation, Genes Dev, 27, 2648, 10.1101/gad.232710.113
Xiang, 2014, Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus, Cell Res, 24, 513, 10.1038/cr.2014.35
Roussel, 1991, Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling, Nature, 353, 361, 10.1038/353361a0
Bowman, 2001, Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis, Proc Natl Acad Sci U S A, 98, 7319, 10.1073/pnas.131568898
Barone, 1995, Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src, Nature, 378, 509, 10.1038/378509a0
Lau, 1987, Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc, Proc Natl Acad Sci U S A, 84, 1182, 10.1073/pnas.84.5.1182
Palomero, 2006, NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth, Proc Natl Acad Sci U S A, 103, 18261, 10.1073/pnas.0606108103
Weng, 2006, c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma, Genes Dev, 20, 2096, 10.1101/gad.1450406
Chou, 2010, EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF, Cancer Res, 70, 8822, 10.1158/0008-5472.CAN-10-0638
Grisanzio, 2010, Chromosome 8q24-associated cancers and MYC, Genes Cancer, 1, 555, 10.1177/1947601910381380
Ahmadiyeh, 2010, 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC, Proc Natl Acad Sci U S A, 107, 9742, 10.1073/pnas.0910668107
Tuupanen, 2009, The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling, Nat Genet, 41, 885, 10.1038/ng.406
Yochum, 2010, A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5′ and 3′ Wnt responsive enhancers, Proc Natl Acad Sci U S A, 107, 145, 10.1073/pnas.0912294107
Eischen, 2001, Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis, Mol Cell Biol, 21, 7653, 10.1128/MCB.21.22.7653-7662.2001
Zindy, 1998, Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization, Genes Dev, 12, 2424, 10.1101/gad.12.15.2424
Muthalagu, 2014, BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues, Cell Rep, 8, 1347, 10.1016/j.celrep.2014.07.057
Kaur, 2013, MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase, Cancer Res, 73, 695, 10.1158/0008-5472.CAN-12-2522
Bouchard, 2007, FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf, Genes Dev, 21, 2775, 10.1101/gad.453107
Qi, 2004, p19ARF directly and differentially controls the functions of c-Myc independently of p53, Nature, 431, 712, 10.1038/nature02958
Bouchard, 2004, Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins, EMBO J, 23, 2830, 10.1038/sj.emboj.7600279
Schmitz, 2012, Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics, Nature, 490, 116, 10.1038/nature11378
Schmitz, 2014, Oncogenic mechanisms in Burkitt lymphoma, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014282
Wolf, 2015, Taming of the beast: shaping Myc-dependent amplification, Trends Cell Biol, 25, 241, 10.1016/j.tcb.2014.10.006
Rahl, 2010, c-Myc regulates transcriptional pause release, Cell, 141, 432, 10.1016/j.cell.2010.03.030
Lin, 2012, Transcriptional amplification in tumor cells with elevated c-Myc, Cell, 151, 56, 10.1016/j.cell.2012.08.026
Levens, 2013, Cellular MYCro economics: balancing MYC function with MYC expression, Cold Spring Harb Perspect Med, 3, 10.1101/cshperspect.a014233
Nie, 2012, c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells, Cell, 151, 68, 10.1016/j.cell.2012.08.033
Guccione, 2006, Myc-binding-site recognition in the human genome is determined by chromatin context, Nat Cell Biol, 8, 764, 10.1038/ncb1434
Dang, 2014, GENE REGULATION Fine-tuned amplification in cells, Nature, 511, 417, 10.1038/nature13518
Sabo, 2014, Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis, Nature, 511, 488, 10.1038/nature13537
Walz, 2014, Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles, Nature, 511, 483, 10.1038/nature13473
Thomas, 2015, Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC, Mol Cell, 58, 440, 10.1016/j.molcel.2015.02.028
Soufi, 2015, Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming, Cell, 161, 555, 10.1016/j.cell.2015.03.017
Soufi, 2012, Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome, Cell, 151, 994, 10.1016/j.cell.2012.09.045
Sander, 2008, MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, 112, 4202, 10.1182/blood-2008-03-147645
Dang, 2014, MYC and the pathway to cancer, 1st ed
van Riggelen, 2010, MYC as a regulator of ribosome biogenesis and protein synthesis, Nat Rev Cancer, 10, 301, 10.1038/nrc2819
Cole, 2009, Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors, Oncogene, 28, 1169, 10.1038/onc.2008.463
Cowling, 2007, The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding, Mol Cell Biol, 27, 2059, 10.1128/MCB.01828-06
Fernandez-Sanchez, 2009, S-adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation, Mol Cell Biol, 29, 6182, 10.1128/MCB.00973-09
Lin, 2008, c-Myc and eIF4F are components of a feedforward loop that links transcription and translation, Cancer Res, 68, 5326, 10.1158/0008-5472.CAN-07-5876
Lin, 2012, Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis, Cell Rep, 1, 325, 10.1016/j.celrep.2012.02.010
Rosenwald, 1993, Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc, Proc Natl Acad Sci U S A, 90, 6175, 10.1073/pnas.90.13.6175
Bywater, 2013, Dysregulation of the basal RNA polymerase transcription apparatus in cancer, Nat Rev Cancer, 13, 299, 10.1038/nrc3496
Wang, 2011, The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation, Immunity, 35, 871, 10.1016/j.immuni.2011.09.021
Rolfe, 1997, Cellular energy utilization and molecular origin of standard metabolic rate in mammals, Physiol Rev, 77, 731, 10.1152/physrev.1997.77.3.731
Gorrini, 2013, Modulation of oxidative stress as an anticancer strategy, Nat Rev Drug Discov, 12, 931, 10.1038/nrd4002
Cairns, 2011, Cancer cell metabolism, Cold Spring Harb Symp Quant Biol, 76, 299, 10.1101/sqb.2011.76.012856
O'sullivan, 2014, Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development, Immunity, 41, 75, 10.1016/j.immuni.2014.06.005
Lagadinou, 2013, BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells, Cell Stem Cell, 12, 329, 10.1016/j.stem.2012.12.013
Samudio, 2010, Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction, J Clin Invest, 120, 142, 10.1172/JCI38942
Lippman, 2009, Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6, Proc Natl Acad Sci U S A, 106, 19928, 10.1073/pnas.0907027106
Neiman, 2011, Sporulation in the budding yeast Saccharomyces cerevisiae, Genetics, 189, 737, 10.1534/genetics.111.127126
Loomis, 2014, Cell signaling during development of Dictyostelium, Dev Biol, 391, 1, 10.1016/j.ydbio.2014.04.001
Lee, 2005, TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium, Mol Biol Cell, 16, 4572, 10.1091/mbc.e05-04-0342
Wang, 2009, Understanding the mechanism of the dormant dauer formation of C. elegans: from genetics to biochemistry, IUBMB Life, 61, 607, 10.1002/iub.211
Jia, 2004, The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span, Development, 131, 3897, 10.1242/dev.01255
Brandhorst, 2015, A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan, Cell Metab, 22, 86, 10.1016/j.cmet.2015.05.012
Berg, 2002, Biochemistry, 5th ed
Hensley, 2013, Glutamine and cancer: cell biology, physiology, and clinical opportunities, J Clin Invest, 123, 3678, 10.1172/JCI69600
Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017
Donnelly, 2013, The eIF2alpha kinases: their structures and functions, Cell Mol Life Sci, 70, 3493, 10.1007/s00018-012-1252-6
Hardie, 2011, AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function, Genes Dev, 25, 1895, 10.1101/gad.17420111
Teleman, 2008, Nutritional control of protein biosynthetic capacity by insulin via Myc in Drosophila, Cell Metab, 7, 21, 10.1016/j.cmet.2007.11.010
Csibi, 2014, The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation, Curr Biol, 24, 2274, 10.1016/j.cub.2014.08.007
Peck, 2013, Antagonism between FOXO and MYC Regulates Cellular Powerhouse, Front Oncol, 3, 96, 10.3389/fonc.2013.00096
Delpuech, 2007, Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression, Mol Cell Biol, 27, 4917, 10.1128/MCB.01789-06
Ferber, 2012, FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression, Cell Death Differ, 19, 968, 10.1038/cdd.2011.179
Jensen, 2011, FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function, EMBO J, 30, 4554, 10.1038/emboj.2011.323
Masui, 2013, mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc, Cell Metab, 18, 726, 10.1016/j.cmet.2013.09.013
Kress, 2011, The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis, Mol Cell, 41, 445, 10.1016/j.molcel.2011.01.023
Cianfanelli, 2015, AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation, Nat Cell Biol, 17, 20, 10.1038/ncb3072
Laplante, 2013, Regulation of mTORC1 and its impact on gene expression at a glance, J Cell Sci, 126, 1713
Okuyama, 2010, Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose, Cancer Res, 70, 10213, 10.1158/0008-5472.CAN-10-2720
Zhang, 2007, HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity, Cancer Cell, 11, 407, 10.1016/j.ccr.2007.04.001
Semenza, 2012, Hypoxia-inducible factors in physiology and medicine, Cell, 148, 399, 10.1016/j.cell.2012.01.021
Ackerman, 2014, Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment, Trends Cell Biol, 24, 472, 10.1016/j.tcb.2014.06.001
Bertout, 2008, The impact of O2 availability on human cancer, Nat Rev Cancer, 8, 967, 10.1038/nrc2540
Chandel, 2000, Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing, J Biol Chem, 275, 25130, 10.1074/jbc.M001914200
Corn, 2005, Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis, Cancer Biol Ther, 4, 1285, 10.4161/cbt.4.11.2299
Gordan, 2007, HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity, Cancer Cell, 11, 335, 10.1016/j.ccr.2007.02.006
D'Angelo, 2003, Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation, J Biol Chem, 278, 38183, 10.1074/jbc.M302244200
Kim, 2004, Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays, Mol Cell Biol, 24, 5923, 10.1128/MCB.24.13.5923-5936.2004
Shim, 1997, c-Myc transactivation of LDH-A: implications for tumor metabolism and growth, Proc Natl Acad Sci U S A, 94, 6658, 10.1073/pnas.94.13.6658
Bello-Fernandez, 1993, The ornithine decarboxylase gene is a transcriptional target of c-Myc, Proc Natl Acad Sci U S A, 90, 7804, 10.1073/pnas.90.16.7804
Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269
Warburg, 1924, Ueber den Stoffwechsel der Tumoren, Biochemische Zeitschrift, 152, 319
DeBerardinis, 2010, Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer, Oncogene, 29, 313, 10.1038/onc.2009.358
Gao, 2009, c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism, Nature, 458, 762, 10.1038/nature07823
Wise, 2008, Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc Natl Acad Sci U S A, 105, 18782, 10.1073/pnas.0810199105
Osthus, 2000, Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc, J Biol Chem, 275, 21797, 10.1074/jbc.C000023200
Fan, 2010, Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition, J Biol Chem, 285, 7324, 10.1074/jbc.M109.035584
Yuneva, 2012, The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type, Cell Metab, 15, 157, 10.1016/j.cmet.2011.12.015
Hu, 2011, 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression, Cell Metab, 14, 131, 10.1016/j.cmet.2011.04.012
David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697
Morrish, 2009, c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry, Oncogene, 28, 2485, 10.1038/onc.2009.112
Locasale, 2013, Serine, glycine and one-carbon units: cancer metabolism in full circle, Nat Rev Cancer, 13, 572, 10.1038/nrc3557
Tedeschi, 2013, Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells, Cell Death Dis, 4, e877, 10.1038/cddis.2013.393
Vazquez, 2013, Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors, Cancer Res, 73, 478, 10.1158/0008-5472.CAN-12-3709
Vazquez, 2011, Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation, PLoS One, 6, e25881, 10.1371/journal.pone.0025881
Sun, 2015, cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions, Cell Res, 25, 429, 10.1038/cr.2015.33
Wonsey, 2002, The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation, Proc Natl Acad Sci U S A, 99, 6649, 10.1073/pnas.102523299
DeBerardinis, 2007, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc Natl Acad Sci U S A, 104, 19345, 10.1073/pnas.0709747104
Son, 2013, Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway, Nature, 496, 101, 10.1038/nature12040
Ye, 2014, Serine catabolism regulates mitochondrial redox control during hypoxia, Cancer Discov, 4, 1406, 10.1158/2159-8290.CD-14-0250
Nikiforov, 2002, A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism, Mol Cell Biol, 22, 5793, 10.1128/MCB.22.16.5793-5800.2002
Fan, 2014, Quantitative flux analysis reveals folate-dependent NADPH production, Nature, 510, 298, 10.1038/nature13236
Doherty, 2014, Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis, Cancer Res, 74, 908, 10.1158/0008-5472.CAN-13-2034
Brahimi-Horn, 2011, Hypoxia and energetic tumour metabolism, Curr Opin Genet Dev, 21, 67, 10.1016/j.gde.2010.10.006
Kung, 2011, Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia, PLoS Genet, 7, e1002229, 10.1371/journal.pgen.1002229
Polletta, 2015, SIRT5 regulation of ammonia-induced autophagy and mitophagy, Autophagy, 11, 253, 10.1080/15548627.2015.1009778
Liu, 2008, Global regulation of nucleotide biosynthetic genes by c-Myc, PLoS One, 3, e2722, 10.1371/journal.pone.0002722
Mannava, 2008, Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells, Cell Cycle, 7, 2392, 10.4161/cc.6390
Miltenberger, 1995, An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants, Mol Cell Biol, 15, 2527, 10.1128/MCB.15.5.2527
Consortium, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247
Zeller, 2006, Global mapping of c-Myc binding sites and target gene networks in human B cells, Proc Natl Acad Sci U S A, 103, 17834, 10.1073/pnas.0604129103
Jones, 1996, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol Cell Biol, 16, 4754, 10.1128/MCB.16.9.4754
Kim, 2000, Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo, Proc Natl Acad Sci U S A, 97, 11198, 10.1073/pnas.200372597
Pourdehnad, 2013, Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers, Proc Natl Acad Sci U S A, 110, 11988, 10.1073/pnas.1310230110
Ruggero, 2009, The role of Myc-induced protein synthesis in cancer, Cancer Res, 69, 8839, 10.1158/0008-5472.CAN-09-1970
Stumpf, 2011, The cancerous translation apparatus, Curr Opin Genet Dev, 21, 474, 10.1016/j.gde.2011.03.007
Barna, 2008, Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency, Nature, 456, 971, 10.1038/nature07449
Cunningham, 2014, Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer, Cell, 157, 1088, 10.1016/j.cell.2014.03.052
Priolo, 2014, AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer, Cancer Res, 74, 7198, 10.1158/0008-5472.CAN-14-1490
Morrish, 2010, Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry, J Biol Chem, 285, 36267, 10.1074/jbc.M110.141606
Edmunds, 2014, c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate, J Biol Chem, 289, 25382, 10.1074/jbc.M114.580662
Zirath, 2013, MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells, Proc Natl Acad Sci U S A, 110, 10258, 10.1073/pnas.1222404110
Iritani, 2002, Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1, EMBO J, 21, 4820, 10.1093/emboj/cdf492
Gomez-Roman, 2003, Direct activation of RNA polymerase III transcription by c-Myc, Nature, 421, 290, 10.1038/nature01327
Grandori, 2005, c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I, Nat Cell Biol, 7, 311, 10.1038/ncb1224
Guo, 2000, Identification of c-myc responsive genes using rat cDNA microarray, Cancer Res, 60, 5922
Johnston, 2014, Socializing with MYC: cell competition in development and as a model for premalignant cancer, Cold Spring Harb Perspect Med, 4, a014274, 10.1101/cshperspect.a014274
de la Cova, 2006, Myc in model organisms: a view from the flyroom, Semin Cancer Biol, 16, 303, 10.1016/j.semcancer.2006.07.010
Johnston, 1999, Drosophila myc regulates cellular growth during development, Cell, 98, 779, 10.1016/S0092-8674(00)81512-3
Lambertsson, 1998, The minute genes in Drosophila and their molecular functions, Adv Genet, 38, 69, 10.1016/S0065-2660(08)60142-X
Brown, 2008, Evolution of the holozoan ribosome biogenesis regulon, BMC Genomics, 9, 442, 10.1186/1471-2164-9-442
Schuhmacher, 1999, Control of cell growth by c-Myc in the absence of cell division, Curr Biol, 9, 1255, 10.1016/S0960-9822(99)80507-7
Schlosser, 2003, A role for c-Myc in the regulation of ribosomal RNA processing, Nucleic Acids Res, 31, 6148, 10.1093/nar/gkg794
Ji, 2011, Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation, PLoS One, 6, e26057, 10.1371/journal.pone.0026057
Koh, 2011, Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene, Am J Pathol, 178, 1824, 10.1016/j.ajpath.2010.12.040
Hofmann, 2015, Reduced expression of MYC increases longevity and enhances healthspan, Cell, 160, 477, 10.1016/j.cell.2014.12.016
Neff, 2013, Rapamycin extends murine lifespan but has limited effects on aging, J Clin Invest, 123, 3272, 10.1172/JCI67674
Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature, 460, 392, 10.1038/nature08221
Martin-Montalvo, 2013, Metformin improves healthspan and lifespan in mice, Nat Commun, 4, 2192, 10.1038/ncomms3192
Scarpulla, 2008, Transcriptional paradigms in mammalian mitochondrial biogenesis and function, Physiol Rev, 88, 611, 10.1152/physrev.00025.2007
O'Donnell, 2006, Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis, Mol Cell Biol, 26, 2373, 10.1128/MCB.26.6.2373-2386.2006
Rouault, 2015, Mammalian iron-sulphur proteins: novel insights into biogenesis and function, Nat Rev Mol Cell Biol, 16, 45, 10.1038/nrm3909
Li, 2005, Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis, Mol Cell Biol, 25, 6225, 10.1128/MCB.25.14.6225-6234.2005
Morrish, 2014, MYC and mitochondrial biogenesis, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014225
Kim, 2008, Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo, PLoS One, 3, e1798, 10.1371/journal.pone.0001798
Ahuja, 2010, Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice, J Clin Invest, 120, 1494, 10.1172/JCI38331
Sheth, 2014, Inhibition of human mitochondrial peptide deformylase causes apoptosis in c-myc-overexpressing hematopoietic cancers, Cell Death Dis, 5, 10.1038/cddis.2014.112
Carroll, 2015, Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis, Cancer Cell, 27, 271, 10.1016/j.ccell.2014.11.024
Weinberg, 2015, Targeting mitochondria metabolism for cancer therapy, Nat Chem Biol, 11, 9, 10.1038/nchembio.1712
Graves, 2012, Mitochondrial structure, function and dynamics are temporally controlled by c-Myc, PLoS One, 7, e37699, 10.1371/journal.pone.0037699
Schuhmacher, 2013, Dose-dependent regulation of target gene expression and cell proliferation by c-Myc levels, Transcription, 4, 192, 10.4161/trns.25907
Bretones, 2015, Myc and cell cycle control, Biochim Biophys Acta, 1849, 506, 10.1016/j.bbagrm.2014.03.013
Hermeking, 2000, Identification of CDK4 as a target of c-MYC, Proc Natl Acad Sci U S A, 97, 2229, 10.1073/pnas.050586197
Bouchard, 2001, Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter, Genes Dev, 15, 2042, 10.1101/gad.907901
Beier, 2000, Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events, EMBO J, 19, 5813, 10.1093/emboj/19.21.5813
Dong, 2014, Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control, Nat Commun, 5, 10.1038/ncomms5750
Zeller, 2003, An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets, Genome Biol, 4, R69, 10.1186/gb-2003-4-10-r69
Aguda, 2008, MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17–92, E2F, and Myc, Proc Natl Acad Sci U S A, 105, 19678, 10.1073/pnas.0811166106
Pickering, 2009, miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression, Oncogene, 28, 140, 10.1038/onc.2008.372
Dominguez-Sola, 2007, Non-transcriptional control of DNA replication by c-Myc, Nature, 448, 445, 10.1038/nature05953
Moncada, 2012, Fulfilling the metabolic requirements for cell proliferation, Biochem J, 446, 1, 10.1042/BJ20120427
Colombo, 2011, Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells, Proc Natl Acad Sci U S A, 108, 21069, 10.1073/pnas.1117500108
Colombo, 2010, Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes, Proc Natl Acad Sci U S A, 107, 18868, 10.1073/pnas.1012362107
Mathews, 2006, DNA precursor metabolism and genomic stability, FASEB J, 20, 1300, 10.1096/fj.06-5730rev
Miller, 2006, A tribute to Sidney Farber– the father of modern chemotherapy, Br J Haematol, 134, 20, 10.1111/j.1365-2141.2006.06119.x
Murphy, 2013, Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells, Metab Eng, 15, 206, 10.1016/j.ymben.2012.07.008
Cermelli, 2014, Synthetic lethal screens as a means to understand and treat MYC-driven cancers, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014209
Toyoshima, 2012, Functional genomics identifies therapeutic targets for MYC-driven cancer, Proc Natl Acad Sci U S A, 109, 9545, 10.1073/pnas.1121119109
Patra, 2013, Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer, Cancer Cell, 24, 399-, 10.1016/j.ccr.2013.08.029
Fantin, 2006, Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, Cancer Cell, 9, 425, 10.1016/j.ccr.2006.04.023
Seth, 2011, On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate, Neoplasia, 13, 60, 10.1593/neo.101020
Wang, 2012, LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis, Breast Cancer Res Treat, 131, 791, 10.1007/s10549-011-1466-6
Xie, 2014, Targeting lactate dehydrogenase–a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells, Cell Metab, 19, 795, 10.1016/j.cmet.2014.03.003
Wang, 2014, Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis, Cell, 158, 1309, 10.1016/j.cell.2014.07.048
Le, 2010, Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression, Proc Natl Acad Sci U S A, 107, 2037, 10.1073/pnas.0914433107
Kolappan, 2015, Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms, Acta Crystallogr D Biol Crystallogr, 71, 185, 10.1107/S1399004714024791
Deiab, 2013, High-throughput screening to identify plant derived human LDH-A inhibitors, European J Med Plants, 3, 603, 10.9734/EJMP/2013/5995
Billiard, 2013, Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells, Cancer Metab, 1, 19, 10.1186/2049-3002-1-19
Kohlmann, 2013, Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors, J Med Chem, 56, 1023, 10.1021/jm3014844
Granchi, 2011, Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells, J Med Chem, 54, 1599, 10.1021/jm101007q
Le, 2012, Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells, Cell Metab, 15, 110, 10.1016/j.cmet.2011.12.009
Wang, 2010, Targeting mitochondrial glutaminase activity inhibits oncogenic transformation, Cancer Cell, 18, 207, 10.1016/j.ccr.2010.08.009
Xiang, 2015, Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis, J Clin Invest, 125, 2293, 10.1172/JCI75836
Gross, 2014, Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer, Mol Cancer Ther, 13, 890, 10.1158/1535-7163.MCT-13-0870
Tan, 2013, Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications, J Biol Chem, 288, 3500, 10.1074/jbc.M112.394510
Zhuang, 2008, C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells, Oncogene, 27, 6623, 10.1038/onc.2008.258
Soucek, 2013, Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice, Genes Dev, 27, 504, 10.1101/gad.205542.112
Ilic, 2011, PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis, Proc Natl Acad Sci U S A, 108, E699, 10.1073/pnas.1108237108
Yuan, 2013, Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma, Proc Natl Acad Sci U S A, 110, 18226, 10.1073/pnas.1317577110
Parmenter, 2014, Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis, Cancer Discov, 4, 423, 10.1158/2159-8290.CD-13-0440
Tanaka, 2015, Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment, J Clin Invest, 125, 1591, 10.1172/JCI78239
Li, 2015, Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells, Proc Natl Acad Sci U S A, 112, E21